Biological Response Modifiers in Combination with Antivirals against Experimentally-Induced Virus Infections

Biological Response Modifiers in Combination with Antivirals against Experimentally-Induced Virus Infections

Biological response modifiers (BRMs) have particular promise when used in combination with more standard antiviral agents for treatment of viral diseases. Reported here are a series of studies which have used two BRMs in combination with the antiviral drug, ribavirin (l-β-o-ribofuranosyl-1,2,4-triaz...

Full description

Saved in:

Bibliographic Details
Main Authors:	Robert W Sidwell, John H Huffman, Donald F Smee, John Gilbert, Roland K Robins, Meir Kende, John Huggins
Format:	Article
Language:	English
Published:	Wiley 1992-01-01
Series:	Canadian Journal of Infectious Diseases
Online Access:	http://dx.doi.org/10.1155/1992/506386
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antiviral and Immunoenhancing Properties of 7-Thia-8-Oxoguanosine and Related Guanosine Analogues
by: Donald F Smee, et al.
Published: (1992-01-01)

Antiviral Activity of Resveratrol against Human and Animal Viruses
by: Yusuf Abba, et al.
Published: (2015-01-01)

Advances and Challenges in Antiviral Development for Respiratory Viruses
by: Luis Adrián De Jesús-González, et al.
Published: (2024-12-01)

Bivalirudin exerts antiviral activity against respiratory syncytial virus-induced lung infections in neonatal mice
by: Zhuang Shihao, et al.
Published: (2022-09-01)

Antiviral and anti-inflammatory activities of favipiravir and quinine sulfate against dengue virus serotype 1 in vitro
by: Regita Aulia Rosalina, et al.
Published: (2025-03-01)

Antiviral Activity of Plant‐Based Additives Against African Swine Fever Virus (ASFV) in Feed Ingredients
by: Thi Ngoc Ha Lai, et al.
Published: (2024-11-01)

Gemcitabine combined with baicalein exerts antiviral activity against PEDV by inhibiting the entry and replication phases
by: Yingge Zheng, et al.
Published: (2025-02-01)

In Vivo and In Vitro Studies Assessing the Antiviral Efficacy of Double Combinations Against Coxsackievirus B Infection
by: Adelina Stoyanova, et al.
Published: (2025-01-01)

Advancements in the development of antivirals against SARS-Coronavirus
by: Mrityunjay Kumar, et al.
Published: (2025-01-01)

Evasion of Early Antiviral Responses by Herpes Simplex Viruses
by: Paula A. Suazo, et al.
Published: (2015-01-01)

Application of Chemically Modified and Unmodified Waste Biological Sorbents in Treatment of Wastewater
by: John Kanayochukwu Nduka
Published: (2012-01-01)

Combined Treatment with Antiviral Therapy and Rituximab in Patients with Mixed Cryoglobulinemia: Review of the Literature and Report of a Case Using Direct Antiviral Agents-Based Antihepatitis C Virus Therapy
by: Teresa Urraro, et al.
Published: (2015-01-01)

The Antiviral Effect of High-Molecular Weight Poly-Gamma-Glutamate against Newcastle Disease Virus on Murine Macrophage Cells
by: Melbourne Talactac, et al.
Published: (2014-01-01)

Exploring the antiviral potential of shikimic acid against Chikungunya virus through network pharmacology, molecular docking, and in vitro experiments
by: Jialiang Xin, et al.
Published: (2025-01-01)

Purine but Not Pyrimidine De Novo Nucleotide Biosynthesis Inhibitors Strongly Enhance the Antiviral Effect of Corresponding Nucleobases Against Dengue Virus
by: Laurent F. Bonnac, et al.
Published: (2025-01-01)

Successful Antiviral Treatment with Direct-Acting Antivirals for Hepatitis C Virus Infection during Peritransplant Period in a Kidney Transplant Recipient
by: Giovanni Varotti, et al.
Published: (2021-01-01)

Antiviral effect of polyphenol rich plant extracts on herpes simplex virus type 1
by: Sayed A. El-Toumy, et al.
Published: (2018-03-01)

A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade
by: Ding Yuan Oh, et al.
Published: (2014-01-01)

Should My Patient with Inflammatory Bowel Disease on Immunosuppressive Therapy be Vaccinated against Influenza Virus?
by: Neeraj Narula, et al.
Published: (2010-01-01)

Predictive Assessment of the Antiviral Properties of Imperata cylindrica against SARS-CoV-2
by: Frank Eric Tatsing Foka, et al.
Published: (2024-01-01)

Advances in antiviral strategies targeting mosquito-borne viruses: cellular, viral, and immune-related approaches
by: Ayyaz Khan, et al.
Published: (2025-02-01)

Treatment of HIV-1 Infection with Combination Therapy: Antiretroviral Agents and Biological Response Modifiers
by: Steven M Schnittman
Published: (1994-01-01)

<i>Hovenia dulcis Thunb</i>. Honey Exerts Antiviral Effect Against Influenza A Virus Infection Through Mitochondrial Stress-Mediated Enhancement of Innate Immunity
by: Eun-Bin Kwon, et al.
Published: (2025-01-01)

Antiviral Activity of Electrospun Polyamide Ultrathin Fibers Against SARS-CoV‑2 Variant
by: Moisés V. Santana, et al.
Published: (2025-01-01)

Recent evidence comparing combination of conventional synthetic disease-modifying antirheumatic drugs with biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
by: Abhishek Zanwar, et al.
Published: (2017-01-01)

p97 Inhibitors Possessing Antiviral Activity Against SARS-CoV-2 and Low Cytotoxicity
by: Rui Ding, et al.
Published: (2025-01-01)

Target-specific peptides for BK virus agnoprotein identified through phage display screening: advancing antiviral therapeutics
by: Xiaofei Xing, et al.
Published: (2025-01-01)

Corrigendum to “Screening a neurotransmitter-receptor-related inhibitor library identifies clomipramine HCl as a potential antiviral compound against Japanese encephalitis virus” [Infectious Medicine 3 (2024) 100130]
by: Yixin Liu, et al.
Published: (2025-03-01)

Antiviral activity of natural compounds extracted from Mediterranean medicinal plants against SARS-CoV-2
by: Stephanie Ghio, et al.
Published: (2024-08-01)

Clinical Development of Biological Response Modifiers
by: Jay P Siegel
Published: (1994-01-01)

Five-Year Prospective Follow-Up of Patients with Hepatitis C Virus Infection Treated with Direct-Acting Antiviral Agents
by: Zhang Y, et al.
Published: (2025-01-01)

Introductory biological statistics /
by: Hampton, Raymond E., et al.
Published: (2019)

Nuclear-Targeting Delivery of CRISPRa System for Upregulation of β-Defensin against Virus Infection by Dexamethasone and Phenylalanine Dual-Modified Dendrimer
by: Mingxiang Zuo, et al.
Published: (2020-01-01)

Editorial: Antiviral monoclonal antibody therapies
by: Catalina Florez, et al.
Published: (2024-10-01)

Influenza A virus hemagglutinin: from classical fusion inhibitors to proteolysis targeting chimera-based strategies in antiviral drug discovery
by: Francisco Javier Hermoso-Pinilla, et al.
Published: (2024-02-01)

The Strategies Used by Animal Viruses to Antagonize Host Antiviral Innate Immunity: New Clues for Developing Live Attenuated Vaccines (LAVs)
by: Na Chen, et al.
Published: (2025-01-01)

Combining Host Plant Resistance, Selective Insecticides, and Biological Control Agents for Integrated Management of Tuta absoluta
by: Peris Wangari Nderitu, et al.
Published: (2020-01-01)

Scaffolded Antigens in Yeast Cell Particle Vaccines Provide Protection against Systemic Polyoma Virus Infection
by: Donald J. Tipper, et al.
Published: (2016-01-01)

Knowledge and awareness of perinatal antiviral use in the prevention of mother-to-child hepatitis B virus transmission among maternal chronic hepatitis carriers
by: Jia Ming Low, et al.
Published: (2024-09-01)

Induction Versus Noninduction Antiviral Therapy for Chronic Hepatitis C Virus in Patients with Congenital Coagulation Disorders: A Canadian Multicentre Trial
by: A Chatterjee, et al.
Published: (2007-01-01)